{
  "meta": {
    "title": "Rh_Isoimmunisation",
    "url": "https://brainandscalpel.vercel.app/rh-isoimmunisation-760405bc.html",
    "scrapedAt": "2025-11-30T11:17:49.646Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">In the first pregnancy, only IgM antibody is formed</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">The chance of significant foetal disease is low, as maternal IgG antibodies do not cross the placenta.</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG antibody titer is very low during the primary immune response</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternal IgG antibodies cross the placenta only after the first delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The consequences of Rh-incompatibility are not serious during the first pregnancy because:</span></p>",
      "unique_key": "DT1193338",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Alloimmunization occurs when an Rh D-negative woman, carrying an Rh D-positive foetus (<strong>who inherited the D antigen from its father</strong>), develops an immune response against the fetal Rh D antigen.</li>\n<li>When an Rh-negative woman carries an Rh-positive foetus, fetal RBCs with the D antigen may enter her bloodstream, usually during delivery. This triggers a <strong>primary immune response</strong>, producing mainly <strong>IgM antibodies</strong>, which are <strong>too large to cross the placenta</strong>. As a result, the first Rh-positive foetus is not affected.</li>\n<li><strong>IgG antibodies that cross the placenta are produced only after a second exposure, </strong>when a rapid memory (amnestic) immune response occurs (<strong>Rules out Options B, C and D</strong>)</li>\n</ul>\n<p><strong>Reference</strong>:</p>\n<p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9593129/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC9593129/</a></p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Advanced maternal age</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Antepartum haemorrhage</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">External cephalic version</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Manual Removal of Placenta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following neither predisposes an Rh-negative female to isoimmunisation nor warrants anti-D immunoglobulin?</span></p>",
      "unique_key": "DT1193342",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<p><strong>Advanced maternal age </strong>does not directly cause fetomaternal haemorrhage or isoimmunisation and is therefore not an indication for anti-D immunoglobulin.</p>\n<p>The following <strong>events increase fetomaternal haemorrhage risk</strong> and thus <strong>isoimmunisation</strong>:</p>\n<ul>\n<li><strong>Miscarriage, MTP, ectopic pregnancy, hydatidiform mole</strong></li>\n<li><strong>Invasive procedures</strong>: Amniocentesis, Chorionic villus sampling (CVS), cordocentesis, embryo reduction</li>\n<li><strong>Antepartum events</strong>: Placenta previa with bleeding, placental abruption, IUFD, external cephalic version, abdominal trauma (<strong>Option B &amp; C ruled out</strong>)</li>\n<li><strong>Delivery-related events</strong>: Vaginal or cesarean delivery, manual removal of placenta (<strong>Option D ruled out</strong>)</li>\n</ul>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Administered (IM) to the mother after delivery</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Given when fetal Rh status is uncertain</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">200 &micro;g is the standard dose</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be given up to 28 days after delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true regarding anti-D postpartum prophylaxis?</span></p>",
      "unique_key": "DT1193365",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The <strong>standard dose is 300 &micro;g</strong>, which covers fetomaternal haemorrhage up to <strong>30 mL of fetal blood</strong>.</p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Administered (IM) to the mother after delivery (Option A): </strong>Anti-D immunoglobulin is routinely administered <strong>intramuscularly postpartum</strong> to Rh-negative mothers.</p>\n<p><strong>Given when fetal Rh status is uncertain (Option B): </strong>When the fetal Rh status is unknown, anti-D prophylaxis is still recommended as <strong>a precaution. </strong></p>\n<p><strong>Can be given up to 28 days after delivery (Option D): </strong>Ideally given within 72 hours, but may be beneficial if administered within 28 days postpartum.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous oedema</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial effusion and/or pleural effusion</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Large placenta</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal anaemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of non-immune fetal hydrops (NIFH)?</span></p>",
      "unique_key": "DT1193373",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193373,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Immune hydrops fetalis <strong>primarily results from red blood cell alloimmunization</strong>, whereas nonimmune hydrops fetalis (NIHF) stems from various conditions, such as cardiac anomalies, infections, or genetic disorders, <strong>which disrupt the fetus's fluid regulation.</strong></p>\n<p>Fetal anaemia is a key feature of <strong>immune hydrops</strong>, caused by <strong>Rh incompatibility</strong>, not NIFH.</p>\n<p><strong>NIFH</strong> is characterised by:</p>\n<ul>\n<li>Increased skin thickness (&gt; 5 mm) / skin oedema (first sign seen on USG)- <strong>Ruled out Option A</strong></li>\n<li>Placental enlargement- <strong>Ruled out Option C</strong></li>\n<li>Pleural effusion- <strong>Ruled out Option B</strong></li>\n<li>Ascites</li>\n<li>The fetus is in Buddha position with a halo around the head.</li>\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Kleihauer test</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Apt test</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Coombs test</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Singer's Alkali denaturation test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old Rh-negative woman delivers a Rh-positive baby. To determine the appropriate dose of anti-D immunoglobulin for postpartum prophylaxis, which of the following tests is used to detect and quantify feto-maternal haemorrhage?</span></p>",
      "unique_key": "DT1193375",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>The Kleihauer-Betke test</strong> is used to detect <strong>fetal RBCs in maternal circulation</strong> by taking advantage of fetal haemoglobin's resistance to acid elution.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250903a40f4262-a172-4af0-aa7d-6926664c5c3e.png\">\n<ul>\n<li>Maternal RBCs lose haemoglobin and appear as pale \"ghost cells,\" while fetal RBCs retain haemoglobin and stain bright pink.</li>\n<li>The number of fetal RBCs allows calculation of the <strong>volume of feto-maternal haemorrhage</strong> and guides <strong>anti-D immunoglobulin dosing</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Apt test (or) Singer's Alkali denaturation test (Options B &amp; D): </strong>This test is based on the <strong>resistance of fetal hemoglobin (HbF) to denaturation by alkaline solutions </strong>(NaOH), as compared to adult hemoglobin (HbA), but it is used to distinguish <strong>fetal blood from maternal blood</strong> in vaginal bleeding, not for quantifying fetal RBCs in maternal blood.</p>\n<p><strong>Coombs test (Option C): </strong>Detects antibodies bound to RBCs (used for diagnosing <strong>hemolytic disease of the newborn</strong>, not quantifying fetal cells).</p>\n<p><strong>Reference</strong>:</p>\n<p><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK430876/\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK430876/</a></p>\n<p><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK224297/\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK224297/</a></p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule an amniocentesis for amniotic fluid bilirubin at 16 weeks</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat anti-D antibody titers after 4 weeks</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer anti-D immunoglobulin now</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule middle cerebral artery peak systolic velocity (MCA-PSV) immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old primigravida at 12 weeks' gestation undergoes routine prenatal testing. Her blood group is A-ve, and her anti-D antibody titer is reported as 1:4. What is the most appropriate next step in management?</span></p>",
      "unique_key": "DT1193384",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193384,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation</strong>:</p>\n<p>In an <strong>Rh-negative mother</strong> with <strong>anti-D antibodies (titer 1:4)</strong>, alloimmunisation has already occurred. A <strong>titer of 1:4</strong> is <strong>below the critical level</strong> (critical titer&nbsp; <strong>&ge; 1:16</strong> or anti-D level <strong>&gt;10 IU/mL</strong> in most centres).</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250903067716e3-ca21-484d-baa2-2e5a78557159.png\">",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}